Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Franchi

Showing results (41-50 of 146) with videos related to

Pageof 15
Sort By:
Journal of Cardiovascular Pharmacology and Therapeutics|June 2, 2017
Role for Thrombin Receptor Antagonism With Vorapaxar in Secondary Prevention of Atherothrombotic Events: From Bench to BedsideJae Youn Moon, Francesco Franchi, Fabiana Rollini, et al.
Therapeutic Advances in Cardiovascular Disease|July 3, 2013
Update on platelet glycoprotein IIb/IIIa inhibitors: recommendations for clinical practiceAna Muñiz-Lozano, Fabiana Rollini, Francesco Franchi, et al.
Expert Review of Hematology|November 2, 2017
The quest for safer antithrombotic treatment regimens in patients with coronary artery disease: new strategies and paradigm shiftsJae Youn Moon, Francesco Franchi, Fabiana Rollini, et al.
Cardiovascular Diagnosis and Therapy|December 1, 2018
Diabetes and antiplatelet therapy: from bench to bedsideJose R Rivas Rios, Francesco Franchi, Fabiana Rollini, et al.
Therapeutic Advances in Hematology|December 6, 2017
The role of oral anticoagulant therapy in patients with acute coronary syndromeJae Youn Moon, Deepa Nagaraju, Francesco Franchi, et al.
Current Treatment Options in Cardiovascular Medicine|March 22, 2014
Platelet function testing in contemporary clinical and interventional practiceFrancesco Franchi, Fabiana Rollini, Jung Rae Cho, et al.
Pharmacogenomics|August 8, 2022
Precision medicine in interventional cardiology: implications for antiplatelet therapy in patients undergoing percutaneous coronary interventionMattia Galli, Luis Ortega-Paz, Francesco Franchi, et al.
Interventional Cardiology Clinics|December 14, 2024
Switching Platelet P2Y<sub>12</sub> Receptor Inhibiting TherapiesLuis Ortega-Paz, Fabiana Rollini, Francesco Franchi, et al.
Vascular Health and Risk Management|April 15, 2014
Unmet needs in the management of acute myocardial infarction: role of novel protease-activated receptor-1 antagonist vorapaxarJung Rae Cho, Fabiana Rollini, Francesco Franchi, et al.
Expert Review of Cardiovascular Therapy|October 22, 2013
Cangrelor: a review on pharmacology and clinical trial developmentFrancesco Franchi, Fabiana Rollini, Ana Muñiz-Lozano, et al.
Pageof 15

Showing results (41-50 of 146) with videos related to

Sort By:
Pageof 15
Journal of Cardiovascular Pharmacology and Therapeutics|June 2, 2017
Role for Thrombin Receptor Antagonism With Vorapaxar in Secondary Prevention of Atherothrombotic Events: From Bench to BedsideJae Youn Moon, Francesco Franchi, Fabiana Rollini, et al.
Therapeutic Advances in Cardiovascular Disease|July 3, 2013
Update on platelet glycoprotein IIb/IIIa inhibitors: recommendations for clinical practiceAna Muñiz-Lozano, Fabiana Rollini, Francesco Franchi, et al.
Expert Review of Hematology|November 2, 2017
The quest for safer antithrombotic treatment regimens in patients with coronary artery disease: new strategies and paradigm shiftsJae Youn Moon, Francesco Franchi, Fabiana Rollini, et al.
Cardiovascular Diagnosis and Therapy|December 1, 2018
Diabetes and antiplatelet therapy: from bench to bedsideJose R Rivas Rios, Francesco Franchi, Fabiana Rollini, et al.
Therapeutic Advances in Hematology|December 6, 2017
The role of oral anticoagulant therapy in patients with acute coronary syndromeJae Youn Moon, Deepa Nagaraju, Francesco Franchi, et al.
Current Treatment Options in Cardiovascular Medicine|March 22, 2014
Platelet function testing in contemporary clinical and interventional practiceFrancesco Franchi, Fabiana Rollini, Jung Rae Cho, et al.
Pharmacogenomics|August 8, 2022
Precision medicine in interventional cardiology: implications for antiplatelet therapy in patients undergoing percutaneous coronary interventionMattia Galli, Luis Ortega-Paz, Francesco Franchi, et al.
Interventional Cardiology Clinics|December 14, 2024
Switching Platelet P2Y<sub>12</sub> Receptor Inhibiting TherapiesLuis Ortega-Paz, Fabiana Rollini, Francesco Franchi, et al.
Vascular Health and Risk Management|April 15, 2014
Unmet needs in the management of acute myocardial infarction: role of novel protease-activated receptor-1 antagonist vorapaxarJung Rae Cho, Fabiana Rollini, Francesco Franchi, et al.
Expert Review of Cardiovascular Therapy|October 22, 2013
Cangrelor: a review on pharmacology and clinical trial developmentFrancesco Franchi, Fabiana Rollini, Ana Muñiz-Lozano, et al.
Pageof 15